{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:55:46Z","timestamp":1790607346627,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.bbmt.2020.03.014","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T17:14:14Z","timestamp":1584638054000},"page":"1225-1232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6268-3300","authenticated-orcid":false,"given":"Hae Lin","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-4627","authenticated-orcid":false,"given":"Scott Y.H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Fitzhugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tisdale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bbmt.2020.03.014_bib0001","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.bbmt.2017.11.018","article-title":"Experiences and decision making in hematopoietic stem cell transplant in sickle cell disease: patients\u2019 and caregivers\u2019 perspectives","volume":"24","author":"Khemani","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2020.03.014_bib0002","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbmt.2018.04.001","article-title":"Shared decision-making in hematopoietic stem cell transplantation for sickle cell disease","volume":"24","author":"Sullivan","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2020.03.014_bib0003","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/bmt.2016.252","article-title":"A qualitative exploration of the informed consent process in hematopoietic cell transplantation clinical research and opportunities for improvement","volume":"52","author":"Raj","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1, suppl 1","key":"10.1016\/j.bbmt.2020.03.014_bib0004","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.amepre.2016.01.024","article-title":"Mistrust of pediatric sickle cell disease clinical trials research","volume":"51","author":"Stevens","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0005","doi-asserted-by":"crossref","unstructured":"Gallo AM, Patil CL, Knafl KA, Angst DA, Rondelli D, Saraf SL. The experience of adults with sickle cell disease and their HLA\u2010matched adult sibling donors after allogeneic hematopoietic stem cell transplantation. J Adv Nurs. 2019;75(11):2943-2951.","DOI":"10.1111\/jan.14152"},{"issue":"11","key":"10.1016\/j.bbmt.2020.03.014_bib0006","first-page":"1050","article-title":"Health-related stigma in young adults with sickle cell disease","volume":"102","author":"Jenerette","year":"2010","journal-title":"J Natl Med Assoc"},{"issue":"5","key":"10.1016\/j.bbmt.2020.03.014_bib0007","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/1043659615575578","article-title":"Barriers to clinical research participation among African Americans","volume":"27","author":"Luebbert","year":"2016","journal-title":"J Transcult Nurs"},{"issue":"2","key":"10.1016\/j.bbmt.2020.03.014_bib0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MLR.0000000000000467","article-title":"Racial and ethnic disparities in health care access and utilization under the Affordable Care Act","volume":"54","author":"Chen","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0009","unstructured":"Centers for Disease Control and Prevention. Data and statistics | sickle cell disease | NCBDDD | CDC.Available at: https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/data.html. Accessed May 2, 2018."},{"issue":"2","key":"10.1016\/j.bbmt.2020.03.014_bib0010","first-page":"116","article-title":"Role of spirituality in patients with sickle cell disease","volume":"14","author":"Cooper-Effa","year":"2001","journal-title":"J Am Board Fam Pract"},{"issue":"4","key":"10.1016\/j.bbmt.2020.03.014_bib0011","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/01.nmd.0000158375.73779.50","article-title":"Religiosity\/spirituality and pain in patients with sickle cell disease","volume":"193","author":"Harrison","year":"2005","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"10.1016\/j.bbmt.2020.03.014_bib0012","article-title":"Spirituality, self-efficacy, and quality of life among adults with sickle cell disease","volume":"11","author":"Adegbola","year":"2011","journal-title":"South Online J Nurs Res"},{"issue":"5","key":"10.1016\/j.bbmt.2020.03.014_bib0013","first-page":"7","article-title":"An approach to evaluating the therapeutic misconception","volume":"31","author":"Kim","year":"2009","journal-title":"IRB"},{"issue":"9","key":"10.1016\/j.bbmt.2020.03.014_bib0014","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"issue":"5","key":"10.1016\/j.bbmt.2020.03.014_bib0015","first-page":"1189","article-title":"Enhancing the quality and credibility of qualitative analysis","volume":"34","author":"Patton","year":"1999","journal-title":"Health Serv Res"},{"issue":"1","key":"10.1016\/j.bbmt.2020.03.014_bib0016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/jama.2014.7192","article-title":"Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype","volume":"312","author":"Hsieh","year":"2014","journal-title":"JAMA"},{"issue":"13-14","key":"10.1016\/j.bbmt.2020.03.014_bib0017","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1111\/jocn.14785","article-title":"Cancer patients\u2019 perceptions of factors influencing their decisions on participation in clinical drug trials: a qualitative meta-synthesis","volume":"28","author":"Nielsen","year":"2019","journal-title":"J Clin Nurs"},{"issue":"4","key":"10.1016\/j.bbmt.2020.03.014_bib0018","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1023\/A:1026072409595","article-title":"Patient expectations of benefit from phase i clinical trials: linguistic considerations in diagnosing a therapeutic misconception","volume":"24","author":"Weinfurt","year":"2003","journal-title":"Theor Med Bioeth"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0019","doi-asserted-by":"crossref","unstructured":"Jansen LA, Mahadevan D, Appelbaum PS, et al. Perceptions of control and unrealistic optimism in early-phase cancer trials. J Med Ethics. 2018;44(2):121-127.","DOI":"10.1136\/medethics-2016-103724"},{"issue":"1","key":"10.1016\/j.bbmt.2020.03.014_bib0020","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1186\/s13063-018-2916-9","article-title":"Patients\u2019 reasoning regarding the decision to participate in clinical cancer trials: an interview study","volume":"19","author":"Dellson","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.bbmt.2020.03.014_bib0021","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/23294515.2015.1034381","article-title":"Cancer clinical trial participants' assessment of risk and benefit","volume":"7","author":"Ulrich","year":"2016","journal-title":"AJOB Empir Bioeth"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0022","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.socscimed.2005.03.039","article-title":"Trials and tribulations: understanding motivations for clinical research participation amongst adults with cystic fibrosis","volume":"61","author":"Lowton","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.11.006","article-title":"\u201cWatching time tick by\u2026\u201d: decision making for Duchenne muscular dystrophy trials","volume":"46","author":"Peay","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0024","doi-asserted-by":"crossref","unstructured":"Turriff A, Blain D, Similuk M, et al. Motivations and decision-making processes of men with X-linked retinoschisis considering participation in an ocular gene therapy trial. Am J Ophthalmol. 2019;204:90-96.","DOI":"10.1016\/j.ajo.2019.03.009"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0025","doi-asserted-by":"crossref","unstructured":"Benz EJ, Mondoro TH, Gibbons GH. Accelerating the science of SCD therapies-is a cure possible? JAMA. 2019. https:\/\/doi.org\/10.1001\/jama.2019.11419. [Epub ahead of print]","DOI":"10.1001\/jama.2019.11419"},{"key":"10.1016\/j.bbmt.2020.03.014_bib0026","unstructured":"Lapook J. Could gene therapy cure sickle cell anemia? CBS News. Available at:https:\/\/www.cbsnews.com\/news\/could-gene-therapy-cure-sickle-cell-anemia-60-minutes\/. Accessed June 14, 2019."},{"key":"10.1016\/j.bbmt.2020.03.014_bib0027","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12910-015-0013-0","article-title":"The ethics of talking about \u2018HIV cure\u2019","volume":"16","author":"Rennie","year":"2015","journal-title":"BMC Med Ethics"},{"issue":"3-4","key":"10.1016\/j.bbmt.2020.03.014_bib0028","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0160-2527(82)90026-7","article-title":"The therapeutic misconception: informed consent in psychiatric research","volume":"5","author":"Appelbaum","year":"1982","journal-title":"Int J Law Psychiatry"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120301518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120301518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:10:37Z","timestamp":1761059437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120301518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1083879120301518"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.03.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}